America's Healthcare Challenge

Public outrage emerged as the price of the popular EpiPen which is used for life-threatening allergic reactions skyrocketed to $600 per pen. Their CEO went to Capitol Hill to defend this recently. This segment explores why the system is to blame.

Vivio Health CEO Pramod John and Chief Experience T.J. Tedesco join the program to discuss how we can use the power of data to improve healthcare.

Explaining the Medicare Modernization Act of 2003 by America's Healthcare Challenge

What kinds of things will we see in the marketplace by America's Healthcare Challenge

Why not give Medicare the power to negotiate with Pharmaceutical companies by America's Healthcare Challenge

Many senior citizens on fixed income are seeing their budgets squeezed by rising costs of prescription drugs and changing formularies. In part four of our ongoing public service to our listening audience, we explore these issues in depth.

Prescription Drug partnerships affecting the marketplace. by America's Healthcare Challenge

AHC Seg 5 by America's Healthcare Challenge

AHC Seg 1 by America's Healthcare Challenge

AHC Seg 3 by America's Healthcare Challenge